A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
Clinical trial NCT01387555 · COMPLETED
Trial details
- NCT number
- NCT01387555
- Sponsor
- Jennerex Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-08
- Primary completion
- 2013-10-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.